WRAL: Local high schools implement safety protocols for outdoor practices amidst record heat wave
Local high schools implement safety protocols for outdoor practices amidst record heat wave
Learn about the family options page of the Windows Security app and how the Microsoft Family Safety app can help protecting your family's digital life.
Use family safety settings to block inappropriate websites and searches on Windows, Xbox and mobile devices.
A family group is a set of individuals connected through the Microsoft Family Safety app on their Windows, Xbox, or mobile devices. Establishing a family group is an easy, effective way to encourage healthy online habits and manage busy schedules.
Find guidance for all things family at Microsoft. Learn about Family Safety, find resources to support your child at school, and get the latest on keeping your information and devices secure.
You can use Microsoft Family Safety to block apps used by family members on Windows, Xbox, Edge, and mobile devices. Select a tab below for instructions on how to use Microsoft Family Safety to block apps.
Learn how to set app, game, and website limits on Windows, Xbox, and Android devices connected through the Microsoft Family Safety app.
In Microsoft Family Safety, two separate roles distinguish individuals in the family group: organizer and member. Family organizers Family organizers are the administrators of a family group. They can add and remove members, manage limits and permissions, and view activity for members that have reporting enabled.
The Microsoft Family Safety app helps empower you and your family to create healthy habits and protect the ones you love. Get peace of mind that your family is staying a little safer while giving your kids independence. Create a safe space for your kids to explore online.
To enable activity reporting and gain insight into their online habits, connect family members' devices through Microsoft Family Safety. This feature allows family organizers to view certain web, search, app and game activity of another family member. This information is accessible through a web browser or the Family Safety app.
In response to one of the hottest summers on record for the state, the N.C. High School Athletic Association has protocols in place to protect student athletes from heat illnesses. Other WRAL Top ...
BocaNewsNow.com: As City Of Boca Raton Seeks New Police Chief, Public Invited To Share Thoughts
The City of Boca Raton just launched a survey to ask residents, others about goals for new police chief. BOCA RATON, FL (BocaNewsNow.com) (Copyright © 2026 MetroDesk Media, LLC) — The City of Boca ...
As City Of Boca Raton Seeks New Police Chief, Public Invited To Share Thoughts
Sun Sentinel: A new Boca Raton police chief? City starts a national search
Boca Raton is looking for a new police chief and is sweeping the United States for candidates, according to city officials. On March 12, city officials announced former Police Chief Michele Miuccio ...
Sun Sentinel: What to know about Boca Raton’s proposed new police headquarters ahead of election
Ahead of the March election, Boca Raton city officials are providing residents with information about a proposal to bring a new police headquarters to the city. Of the two questions on the ballot, the ...
What to know about Boca Raton’s proposed new police headquarters ahead of election
Bimekizumab demonstrated a consistent safety profile across patients with PsA or axSpA in an integrated safety analysis, with the drug showing long-term tolerability.
Nasdaq: Immix Biopharma Reports Class-Leading Safety Profile for CAR-T NXC-201 in Low-Volume AL Amyloidosis, On Track for BLA Submission
Absence of neurotoxicity of any grade in low-volume disease to-date highlights a significant safety profile for NXC-201, which is crucial for patient acceptance and regulatory approval. Company is on ...
Immix Biopharma Reports Class-Leading Safety Profile for CAR-T NXC-201 in Low-Volume AL Amyloidosis, On Track for BLA Submission
Yahoo Finance: Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
BioSpace: Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns
Right after the FDA flagged safety concerns for Eli Lilly’s newly approved obesity pill, the pharma posted diabetes data demonstrating a clean safety profile and revealed plans to seek approval in the ...
The 5-year “real-world” safety profile of esketamine nasal spray for depression was consistent with prior clinical trial data, with most adverse events (AEs) being transient and serious AEs observed ...
MADRID — Real-world data on tirzepatide (Eli Lilly and Company) from a large population database suggest a safety profile of the drug consistent with that in clinical trials and similar to that of ...
World Socialist Web Site: Massive study confirms safety profile of COVID-19 vaccines
A study on 93 million individuals worldwide who received one of the major COVID-19 vaccines confirmed existing knowledge about the safety profile of these vaccines. Adverse events of special interest ...
The American Journal of Managed Care: Zanubrutinib's Safety Profile in CLL Reinforced in 5-Year Follow-Up of SEQUOIA
The SEQUOIA study's 5-year follow-up confirms zanubrutinib's safety profile and low cardiovascular events in treatment-naive chronic lymphocytic leukemia, according to Mazyar Shadman, MD, MPH, of Fred ...
PharmiWeb: ICOTYDE™ (icotrokinra) one-year results demonstrate lasting skin clearance and favourable safety profile in once-daily tablet for plaque psoriasis
ICOTYDE™ (icotrokinra) one-year results demonstrate lasting skin clearance and favourable safety profile in once-daily tablet for plaque psoriasis
ascopubs.org: Comparative safety profiles of lutetium-177 and enzalutamide: A pharmacovigilance study and disproportionality analysis using real world data.
Comparative safety profiles of lutetium-177 and enzalutamide: A pharmacovigilance study and disproportionality analysis using real world data.
Seeking Alpha: Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC
Phase 1 data demonstrates durable responses and rPFS coupled with a manageable safety profile rPFS of 7.9-8.9 months in heavily pre-treated mCRPC patients Preliminary results are encouraging with deep ...
Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC
Nasdaq: Kymera Therapeutics Reports Positive Phase 1 Results for KT-621, a Once-Daily Oral STAT6 Degrader, Surpassing Targets and Demonstrating Strong Safety Profile